Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.
- Revenue: $118.38M. Running result $118.38M. Antibody Discovery: $56.57M. Ngs Tools: $61.81M.
- Cost of revenue: −$55.92M. Running result $62.45M.
- Gross profit: $62.45M. Running result $62.45M.
- Research and development expenses: −$18.03M. Running result $44.43M.
- Selling, general and administrative expenses: −$80.71M. Running result −$36.28M.
- Litigation settlement costs, net of recoveries: $0. Running result −$36.28M.
- Operating income: −$36.28M. Running result −$36.28M.
- Other income: $1.54M. Running result −$34.74M.
- Pre-tax loss: −$34.74M. Running result −$34.74M.
- Income tax expense: −$311K. Running result −$35.05M.
- Net loss: −$35.05M. Running result −$35.05M.
